The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia.
We aimed to evaluate the incremental cost-effectiveness of engaging private practitioners (PPs) to refer tuberculosis (TB) suspects to public health centers in Jogjakarta, Indonesia. Effectiveness was assessed for TB suspects notified between May 2004 and April 2005. Private practitioners referred 1,064 TB suspects, of which 57.5% failed to reach a health center. The smear-positive rate among patients reaching a health center was 61.8%. Two hundred eighty (280) out of a total of 1,306 (21.4%) new smear-positive cases were enrolled through the PPs strategy. The incremental cost-effectiveness ratio per smear-positive case successfully treated for the PPs strategy was US$351.66 (95% CI 322.84-601.33). On the basis of an acceptability curve using the National TB control program's willingness-to-pay threshold (US$448.61), we estimate the probability that the PPs strategy is cost-effective at 66.8%. The strategy of engaging PPs was incrementally cost-effective, although under specific conditions, most importantly a well-functioning public directly observed treatment, short-course (DOTS) program.
Department of Public Health, Faculty of Medicine, Gadjah Mada University, Jogjakarta, Indonesia. yodi_mahendradhata@yahoo.co.uk
Yodi
Y
Mahendradhata
Ari
A
Probandari
Riris A
RA
Ahmad
Adi
A
Utarini
Laksono
L
Trisnantoro
Lars
L
Lindholm
Marieke J
MJ
van der Werf
Michael
M
Kimerling
Marleen
M
Boelaert
Benjamin
B
Johns
Patrick
P
Van der Stuyft
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D023801:Directly Observed Therapy; D006801:Humans; D007214:Indonesia / Q000453:epidemiology; D010818:Practice Patterns, Physicians' / Q000191:economics*; D012017:Referral and Consultation; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology*
D000995:Antitubercular Agents